A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2011
10/26/2011	CN102225896A Ether derivatives of rhein and their therapeutic use
10/26/2011	CN102225894A Preparation method of soluble calcium citrate trihydrate
10/26/2011	CN102225205A Tripterine nano structure lipid carrier and preparation method and application thereof
10/26/2011	CN102225200A Methods and compositions for modulating TWEAK and FN14 activity
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225192A Plaster for treating bone fracture and preparation method thereof
10/26/2011	CN102225178A Fructus galangae extract and medicinal application thereof
10/26/2011	CN102225138A Traditional Chinese medicine composition for treating fracture and preparation method and application thereof
10/26/2011	CN102225130A Traditional Chinese medicine compound for treating rheumatoid arthritis and preparation method thereof
10/26/2011	CN102225129A Traditional Chinese medicine composite for treating degenerative osteoarthritis and preparation method thereof
10/26/2011	CN102225125A Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
10/26/2011	CN102225115A Chinese patent medicine oral pill for treating rheumatic arthralgia
10/26/2011	CN102225109A Quick-acting fracture setting medicine powder
10/26/2011	CN102225108A Medicinal liquor for treating lumbago and protrusion of lumbar vertebral disc
10/26/2011	CN102225102A Medicinal liquor for treating rheumatoid arthritis
10/26/2011	CN102225096A Rumex acetosa linn cataplasm and preparation method thereof
10/26/2011	CN102225081A Thorny elaeagnus extract as well as preparation method and application thereof
10/26/2011	CN102225070A Calcium carbonate effervescent granule
10/26/2011	CN102225047A Enteric solid oral dosage form of bisphosphonate containing a chelating agent
10/26/2011	CN102224989A Water bed
10/26/2011	CN102224973A Socks capable of preventing and curing gout by wearing to sleep
10/26/2011	CN102058651B Medical composition for preventing and treating osteoporosis
10/26/2011	CN101979074B Traditional Chinese medicine for treating rheumatoid arthritis
10/26/2011	CN101919988B Medicine compound for curing rheumatism rheumatoid arthritis and preparation method thereof
10/26/2011	CN101856440B Chinese medicinal composition for treating knee sore pain
10/26/2011	CN101851291B Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/26/2011	CN101791344B Traditional Chinese medicine and preparation method thereof
10/26/2011	CN101703584B Externally applied medicament for treating hyperosteogeny and hand-foot corn
10/26/2011	CN101632723B Application of compound polygonum orientale preparation in preventing and treating climacteric diseases and delaying senility
10/26/2011	CN101579388B Medicinal composition for treating osteoporosis and preparation method thereof
10/26/2011	CN101199620B Oral administration medicated liquor for treating sprain
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044070 Heteroaryloxy nitrogenous saturated heterocyclic derivative
10/25/2011	US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8044037 Modified phosphocalcic compound, injectable composition containing same
10/25/2011	US8043831 Therapeutic agents comprising pro-apoptotic proteins
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/25/2011	CA2531454C Use of rapamycin and rapamycin derivatives for the treatment of bone loss
10/25/2011	CA2460834C Matrix metalloproteinase inhibitor
10/25/2011	CA2454658C Methods for treating joint inflammation, pain, and loss of mobility
10/20/2011	WO2011130611A2 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
10/20/2011	WO2011129424A1 Pharmaceutical agent for prevention and/or treatment of htlv-1-associated myelopathy
10/20/2011	WO2011127629A1 Pharmaceutical product of diphosphonate injection and preparation method thereof
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011127543A1 Proteins that bind pi16 and uses thereof
10/20/2011	WO2011063394A3 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
10/20/2011	WO2011044443A3 Matricryptic ecm peptides for tissue reconstruction
10/20/2011	WO2011034896A3 Small molecule inhibitors of the alpha4-paxillin interaction
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257381 Pharmaceutical composition comprising chito-oligomers
10/20/2011	US20110257271 Derivatives of dimethylcurcumin
10/20/2011	US20110257249 Drug carriers
10/20/2011	US20110257244 Chemically modified oligonucleotides and small molecules for use in reducing micro rna activity levels and uses thereof
10/20/2011	US20110257232 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
10/20/2011	US20110257223 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257210 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257165 Bicyclic pyrazoles as protein kinase inhibitors
10/20/2011	US20110257131 Phenylalkyl-imidazole-bisphosphonate compounds
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257123 Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
10/20/2011	US20110257117 Olive compositions and methods for treating inflammatory conditions
10/20/2011	US20110257113 Method for Inducing a Trif-Bias
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257094 Anti periodontitis-causing microorganism agent and medical or dental materials using the same
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110257074 Method for the purification of substituted cyclopent-2-en-1-one congeners and substituted 1,3-cyclopentadione congeners from a complex mixture using countercurrent separation
10/20/2011	US20110256246 Essential oil of kunzea ambigua and methods of use
10/20/2011	US20110256228 Solid Forms for Tissue Repair Background of the Invention
10/20/2011	US20110256224 Methods and compositions for targeted delivery
10/20/2011	US20110256222 Recombinant Protein Enriched in a Heparin Binding Site and/or in a Heparan Sulfate Binding Site
10/20/2011	US20110256217 Pulsatile release compositions and methods for enhanced intestinal drug absorption
10/20/2011	US20110256203 Porous ceramic scaffold having an organic/inorganic hybrid coating layer containing bioactive factor and method thereof
10/20/2011	US20110256186 biomaterial based on wharton's jelly from the human umbilical cord
10/20/2011	US20110256160 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256159 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256145 Connective Tissue Growth Factor-3 (CTGF-3)
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256130 Methods of treating inflammatory disorders
10/20/2011	US20110256127 Anti-lrp6 antibodies
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256123 Methods and uses of leptin in immune modulation and hepatocellular carcinoma
10/20/2011	US20110256109 Chondrogenic progenitor cells, protocol for derivation of cells and uses thereof
10/20/2011	US20110256106 Methods and Compositions for Treating Intervertebral Disc Degeneration
10/20/2011	US20110256100 Secreted modular calcium binding protein for intracellular modulation of bone morphogenetic protein signaling
10/20/2011	US20110256095 Tissue Matrix System
10/20/2011	US20110256093 Treating Disorders Associated with IL-20 Receptor-Mediated Signaling Pathway by Blocking IL-20 Receptor Activity
10/20/2011	US20110256091 Antibody-Targeted Cytokines for Therapy
10/20/2011	US20110256061 Binding agents to the Integrin Alpha-11 subunit, and uses thereof
10/20/2011	CA2796064A1 Treating disorders associated with il-20 receptor-mediated signaling pathway by blocking il-20 receptor activity
10/20/2011	CA2795078A1 Proteins that bind pi16 and uses thereof
10/19/2011	EP2377932A1 ANTI-Siglec-15 ANTIBODY
10/19/2011	EP2377926A1 Chondrocyte-like cell, and method for producing same
10/19/2011	EP2377542A2 Pharmaceutical composition for bone-disease treatment or countering inflammation, comprising cartilage stem cells as an active principle
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP2376490A1 Imidazopyridine compounds

1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 820